Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03899155
PHASE2

Pan Tumor Rollover Study

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

Official title: Pan-Tumor Study for Long-term Treatment of Cancer Patients Who Have Participated in BMS Sponsored Trials Investigating Nivolumab and Other Cancer Therapies

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1500

Start Date

2019-08-09

Completion Date

2029-08-25

Last Updated

2026-10-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

Nivolumab

Specified dose on specified days

DRUG

Ipilimumab

Specified dose on specified days

DRUG

Cabozantinib

Specified dose on specified days

DRUG

Trametinib

Specified dose on specified days

DRUG

Relatlimab

Specified dose on specified days

DRUG

Nivolumab + Relatlimab

Specified dose on specified days

DRUG

Capecitabine

Specified dose on specified days

DRUG

Bevacizumab

Specified dose on specified days

DRUG

Temozolomide

Specified dose on specified days

DRUG

Rucaparib

Specified dose on specified days

DRUG

Daratumumab

Specified dose on specified days

DRUG

Regorafinib

Specified dose on specified days

DRUG

Leucovorin

Specified dose on specified days

DRUG

Fluorouracil

Specified dose on specified days

DRUG

Oxaliplatin

Specified dose on specified days

DRUG

Enzalutamide

Specified dose on specified days

DRUG

Sunitinib

Specified dose on specified days

DRUG

Pemetrexed

Specified dose on specified days

DRUG

Pembrolizumab

Specified dose on specified days

Locations (410)

Local Institution - 0220

Huntsville, Alabama, United States

University of Arizona College of Medicine

Tucson, Arizona, United States

Innovative Clinical Research Institute

Lynwood, California, United States

Local Institution

San Francisco, California, United States

Local Institution - 0099

San Francisco, California, United States

Local Institution - 0233

Aurora, Colorado, United States

Local Institution - 0095

New Haven, Connecticut, United States

Local Institution - 0088

Washington D.C., District of Columbia, United States

Florida Cancer Affiliates

Ocala, Florida, United States

Local Institution

Orlando, Florida, United States

Local Institution - 0024

Tampa, Florida, United States

Local Institution - 0105

Chicago, Illinois, United States

Local Institution

Maywood, Illinois, United States

Local Institution - 0279

Park Ridge, Illinois, United States

Local Institution - 0186

Westwood, Kansas, United States

Local Institution - 0165

Wichita, Kansas, United States

University of Louisville-James Graham Brown Cancer Center

Louisville, Kentucky, United States

Local Institution - 0092

Baltimore, Maryland, United States

Local Institution - 0039

Boston, Massachusetts, United States

Dana_Farber Cancer Institute (DFCI)

Boston, Massachusetts, United States

Local Institution - 0081

Boston, Massachusetts, United States

Local Institution - 0143

Ann Arbor, Michigan, United States

Local Institution - 0100

Minneapolis, Minnesota, United States

Local Institution

St Louis, Missouri, United States

Local Institution - 0205

Omaha, Nebraska, United States

Local Institution - 0014

Lebanon, New Hampshire, United States

Local Institution

Albuquerque, New Mexico, United States

Local Institution - 0128

Buffalo, New York, United States

NYU Langone Hematology Oncology Associates-Mineola

Mineola, New York, United States

Local Institution

New York, New York, United States

Local Institution - 0185

New York, New York, United States

Local Institution - 0202

New York, New York, United States

Local Institution

New York, New York, United States

Local Institution - 0204

Charlotte, North Carolina, United States

Local Institution - 0016

Durham, North Carolina, United States

Oncology Hematology Care

Cincinnati, Ohio, United States

Local Institution - 0408

Cincinnati, Ohio, United States

Local Institution

Cleveland, Ohio, United States

The Ohio University

Columbus, Ohio, United States

Local Institution - 0246

Tulsa, Oklahoma, United States

Local Institution - 0037

Allentown, Pennsylvania, United States

Local Institution - 0054

Easton, Pennsylvania, United States

Lancaster General Health

Lancaster, Pennsylvania, United States

Allegheny Valley Hospital

Natrona Heights, Pennsylvania, United States

Local Institution

Philadelphia, Pennsylvania, United States

Local Institution - 0162

Philadelphia, Pennsylvania, United States

Local Institution - 0110

Pittsburgh, Pennsylvania, United States

Local Institution - 0228

Charleston, South Carolina, United States

Local Institution

Greenville, South Carolina, United States

Local Institution

Chattanooga, Tennessee, United States

Tennesse Oncology

Nashville, Tennessee, United States

Local Institution - 0066

Nashville, Tennessee, United States

Local Institution

Dallas, Texas, United States

Local Institution - 0364

Houston, Texas, United States

Local Institution - 0055

Salt Lake City, Utah, United States

Local Institution

Charlottesville, Virginia, United States

Public Hospital of King County District 1 Valley Medical Center

Renton, Washington, United States

Local Institution - 0065

Madison, Wisconsin, United States

Local Institution - 0124

Madison, Wisconsin, United States

Local Institution - 0199

Berazategui, Buenos Aires, Argentina

Local Institution - 0422

Buenos Aires, Buenos Aires F.D., Argentina

Local Institution - 0421

CABA, Capital Federal (c.a.b.a), Argentina

Instituto Medico Rio Cuarto

Río Cuarto, Córdoba Province, Argentina

Centro de Investigaciones Clinicas. Clinica Viedma S.A.

Viedma, Río Negro Province, Argentina

Sanatorio Parque

Rosario, Santa Fe Province, Argentina

CAIPO Centro para la Atencion Integral del Paciente Oncologico

San Miguel de Tucumán, Tucumán Province, Argentina

Local Institution - 0191

San Miguel de Tucumán, Tucumán Province, Argentina

Local Institution - 0201

Buenos Aires, Argentina

Instituto Fleming

Buenos Aires, Argentina

Local Institution

CABA, Argentina

Fundacion Richardet Longo - IONC

Córdoba, Argentina

Local Institution - 0170

Córdoba, Argentina

Local Institution - 0045

Coffs Harbour, New South Wales, Australia

Melanoma Institute Australia

North Sydney, New South Wales, Australia

Local Institution - 0009

Sydney, New South Wales, Australia

Local Institution - 0193

Waratah, New South Wales, Australia

Local Institution - 0208

Westmead, New South Wales, Australia

Gallipoli Medical Foundation

Greenslopes, Queensland, Australia

Local Institution - 0372

Greenslopes, Queensland, Australia

Local Institution

South Brisbane, Queensland, Australia

Tasman Oncology Research Ltd

Southport, Queensland, Australia

Local Institution

Adelaide, South Australia, Australia

Local Institution - 0196

Elizabeth Vale, South Australia, Australia

BRICC - Ballarat Health Services

Ballarat, Victoria, Australia

Local Institution - 0365

Fitzroy, Victoria, Australia

Cabrini Hospital Malvern

Malvern, Victoria, Australia

Local Institution - 0174

Murdoch, Western Australia, Australia

Local Institution - 0254

Graz, Styria, Austria

Ordensklinikum Linz GmbH Elisabethinen

Linz, Upper Austria, Austria

Local Institution - 0418

Sankt Pölten, Austria

Local Institution - 0104

Vienna, Austria

Local Institution - 0321

Vienna, Austria

Local Institution - 0145

Wels, Austria

Local Institution - 0329

Brussels, Belgium

Local Institution - 0232

Ghent, Belgium

Local Institution - 0139

Jette, Belgium

Local Institution - 0261

Liège, Belgium

Local Institution - 0293

Sint-Niklaas, Belgium

Local Institution - 0157

Yvoir, Belgium

Local Institution - 0260

Belo Horizonte, Minas Gerais, Brazil

And 310 more locations on ClinicalTrials.gov